I. García-García
发表
P. López-Saura,
C. Valenzuela-Silva,
R. Suárez-Méndez,
2004,
BMC infectious diseases.
P. López-Saura,
C. Valenzuela-Silva,
R. Suárez-Méndez,
2012
.
L. González-Méndez,
P. López-Saura,
C. Valenzuela-Silva,
2008,
BMC infectious diseases.
E. García‐Iglesias,
I. García-García,
I. Bello-Rivero,
2012,
BMC Pharmacology and Toxicology.
P. López-Saura,
C. A. González-Delgado,
C. Valenzuela-Silva,
2010,
BMC pharmacology.
P. López-Saura,
C. Valenzuela-Silva,
Raúl Herrera-Valdés,
2005,
BMC nephrology.
P. López-Saura,
C. A. González-Delgado,
C. Valenzuela-Silva,
2005,
Biopharmaceutics & drug disposition.
P. López-Saura,
C. A. González-Delgado,
C. Valenzuela-Silva,
2004
.
C. A. González-Delgado,
I. García-García,
Alina Díaz-Machado,
2017
.
R. Rodríguez-Labrada,
L. Velázquez-Pérez,
Ricardo Ortega-Sánchez,
2022,
Movement disorders : official journal of the Movement Disorder Society.
C. A. González-Delgado,
Yolanda Cruz-Gómez,
J. García-Rodríguez,
2017,
BMC Neurology.
A. Borobia,
C. Solano,
A. Carcas,
2021,
Trials.
P. López-Saura,
C. A. González-Delgado,
C. Valenzuela-Silva,
2016,
BMC Pharmacology and Toxicology.
A. Borobia,
F. Abad‐Santos,
D. Páez,
2021,
Clinical and Translational Oncology.
P. López-Saura,
C. A. González-Delgado,
C. Valenzuela-Silva,
2016,
BMC Pharmacology and Toxicology.
P. López-Saura,
C. A. González-Delgado,
C. Valenzuela-Silva,
2004,
Drugs in R&D.
R. Delgado-Hernández,
I. García-García,
Á. Tuero-Iglesias,
2016
.
D. Alonso,
L. González-Méndez,
C. Valenzuela-Silva,
2018
.
I. García-García,
Daise Jiménez-Rodríguez,
Jorge E. Rodríguez-Chanfrau,
2016
.
E. García‐Iglesias,
I. García-García,
I. Bello-Rivero,
2012,
BMC Pharmacology and Toxicology.